Total Payments
$536.09
2023 Payments
$35.57
Companies
12
Transactions
35
Medicare Patients
7,153
Medicare Billing
$262,524
Payment Breakdown by Category
Food & Beverage$517.20 (96.5%)
Education$18.89 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $517.20 | 33 | 96.5% |
| Education | $18.89 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $172.35 | 9 | $0 (2017) |
| Novo Nordisk Inc | $76.02 | 6 | $0 (2023) |
| Lilly USA, LLC | $72.15 | 5 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $53.18 | 3 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.91 | 3 | $0 (2017) |
| Orexigen Therapeutics, Inc. | $35.41 | 3 | $0 (2017) |
| Exact Sciences Corporation | $22.68 | 1 | $0 (2023) |
| PFIZER INC. | $17.52 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $12.83 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $12.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $35.57 | 2 | Exact Sciences Corporation ($22.68) |
| 2019 | $11.17 | 1 | Novo Nordisk Inc ($11.17) |
| 2018 | $14.43 | 1 | Lilly USA, LLC ($14.43) |
| 2017 | $474.92 | 31 | AstraZeneca Pharmaceuticals LP ($172.35) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Oncology | ||||||
| 01/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Diabetes | ||||||
| 05/16/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: Diabetes | ||||||
| 08/23/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 09/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 07/25/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/12/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 06/26/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.61 | General |
| 06/20/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Diabetes | ||||||
| 06/13/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/07/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/25/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Respiratory | ||||||
| 05/22/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: OBESITY | ||||||
| 04/18/2017 | PFIZER INC. | PREMARIN ORALS (Drug), ESTRING, PVC | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: WOMENS HEALTH | ||||||
| 04/11/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 03/24/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.57 | General |
| 03/13/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: OBESITY | ||||||
| 03/07/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: DIABETES | ||||||
| 02/27/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Respiratory | ||||||
| 02/24/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,755 | 2,459 | $156,848 | $65,687 |
| 2022 | 29 | 1,790 | 2,489 | $158,178 | $63,114 |
| 2021 | 25 | 1,707 | 2,435 | $177,910 | $72,097 |
| 2020 | 27 | 1,901 | 2,454 | $168,877 | $61,626 |
Total Patients
7,153
Total Services
9,837
Medicare Billing
$262,524
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 223 | $48,837 | $17,470 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $29,040 | $15,367 | 52.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $11,928 | $5,916 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 62 | $9,300 | $3,681 | 39.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 148 | 191 | $9,168 | $3,144 | 34.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 147 | 210 | $7,770 | $2,731 | 35.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 162 | 261 | $7,569 | $2,701 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 165 | 269 | $2,690 | $2,252 | 83.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 29 | 29 | $4,205 | $2,198 | 52.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 159 | 249 | $5,478 | $1,895 | 34.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 144 | 188 | $4,700 | $1,646 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 43 | $2,193 | $1,303 | 59.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 91 | 137 | $3,699 | $1,296 | 35.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 20 | $1,500 | $580.20 | 38.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $1,062 | $545.40 | 51.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 15 | 15 | $690.00 | $498.63 | 72.3% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 34 | 57 | $1,368 | $450.87 | 33.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 24 | 45 | $1,080 | $381.58 | 35.3% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 24 | 45 | $1,080 | $356.40 | 33.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 21 | 24 | $1,008 | $354.72 | 35.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 91 | 111 | $999.00 | $342.46 | 34.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 40 | 46 | $598.00 | $281.06 | 47.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 40 | 46 | $690.00 | $233.68 | 33.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 28 | $196.00 | $61.60 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 244 | $53,436 | $19,594 | 36.7% |
About Dr. Rachael Dabelic, M.D
Dr. Rachael Dabelic, M.D is a Family Medicine healthcare provider based in Lake Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194760074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachael Dabelic, M.D has received a total of $536.09 in payments from pharmaceutical and medical device companies, with $35.57 received in 2023. These payments were reported across 35 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($517.20).
As a Medicare-enrolled provider, Dabelic has provided services to 7,153 Medicare beneficiaries, totaling 9,837 services with total Medicare billing of $262,524. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lake Worth, TX
- Active Since 06/17/2006
- Last Updated 10/23/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194760074
Products in Payments
- FARXIGA (Drug) $122.64
- TRULICITY (Drug) $72.15
- STIOLTO (Drug) $36.91
- CONTRAVE (Drug) $35.41
- TOUJEO (Drug) $28.78
- Victoza (Drug) $25.95
- BEVESPI AEROSPHERE (Drug) $25.76
- SOLIQUA (Drug) $24.40
- Cologuard Collection Kit (Device) $22.68
- PREMARIN ORALS (Drug) $17.52
- Rybelsus (Drug) $12.89
- XIFAXAN (Drug) $12.83
- UTIBRON (Drug) $12.56
- BREO (Drug) $12.41
- JANUVIA (Drug) $12.07
- SYMBICORT (Drug) $11.34
- Tresiba (Drug) $11.17
- Levemir (Drug) $10.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake Worth
Elizabeth Gunther, D.o, D.O
Family Medicine — Payments: $12,014
Family Medicine $12,014
Rafael Ubeda, Md, MD
Family Medicine — Payments: $4,997
Family Medicine $4,997
Dr. David Simon, Do, DO
Family Medicine — Payments: $4,545
Family Medicine $4,545
Dr. Mary Scanlon, Do, DO
Family Medicine — Payments: $1,593
Family Medicine $1,593
Antonella Berger, Arnp, ARNP
Family Medicine — Payments: $1,441
Family Medicine $1,441
Ms. Shelly Kramer, Arnp, ARNP
Family Medicine — Payments: $1,022
Family Medicine $1,022